NCT02139319View on ClinicalTrials.gov

Dose-Escalation of Botulinum Toxin in Subjects With Osteoarthritis of the Knee

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions

Knee Osteoarthritis

Interventions

DRUG

Botulinum toxin

DRUG

Placebo

Trial Locations (1)

Unknown

London

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Galderma R&D

INDUSTRY